2-OH-E1 % (Pre-menopausal)
2-OH-E1 % is the percentage of estrone (E1) that your body converts down the 2-hydroxylation pathway to 2-hydroxyestrone. It’s a distribution marker, not a raw hormone level: it shows how your estrogen metabolism is partitioned among pathways (2-OH, 4-OH, 16-OH). Results are reported from a spot urine sample, typically normalized to creatinine, so hydration has less impact.
Why it matters
Your body breaks down estrogens through several Phase I pathways:
-
2-hydroxylation (this marker): makes 2-hydroxyestrone, a less estrogenic “catechol” estrogen. It is usually considered a benign/neutral route when it is subsequently methylated by COMT to 2-methoxy metabolites.
-
4-hydroxylation: produces reactive catechols that can form quinones if not well methylated/neutralized.
-
16-hydroxylation: yields 16α-OH-E1, a more estrogenic metabolite that can act longer at receptors.
A healthy pattern is balanced, within your lab’s reference ranges. This marker does not diagnose cancer risk and shouldn’t be used alone to predict disease—it’s a metabolic snapshot that helps you and your clinician see where estrogen is being routed.
How to read your result (always use your lab’s reference range)
-
Lower 2-OH-E1 % (shift away from 2-pathway):
Suggests a relative preference for 16-OH and/or 4-OH pathways. In context with other metabolites, this may reflect lower CYP1A activity, certain medications, or lifestyle factors. Clinically, the goal is not “max 2-OH,” but an appropriate balance with good downstream neutralization (methylation, glucuronidation, sulfation). -
Higher 2-OH-E1 % (shift toward 2-pathway):
Indicates more estrone is routed to 2-hydroxylation. On its own, that’s often fine—especially if 2-methoxy metabolites are also adequate (showing COMT is methylating well). If 2-OH-E1 % is high but 2-methoxy levels are low, discuss methylation support and overall antioxidant status with your clinician.
Pair this marker with its “downstream” partner. High 2-OH alongside low 2-methoxy suggests bottlenecks in methylation (COMT); low 2-OH with high 16-OH shows a different pattern and a different plan.
What can influence 2-OH-E1 %
-
Dietary patterns: Cruciferous vegetables (broccoli, kale, cabbage), I3C/DIM supplements, and a diet rich in polyphenols can tilt metabolism toward 2-hydroxylation; always use supplements judiciously and with clinician guidance.
-
Alcohol, caffeine, tobacco smoke, and charred foods: Can modify CYP enzymes (Phase I) and shift pathway percentages.
-
Medications/supplements: Certain drugs (e.g., enzyme inducers/inhibitors), proton-pump inhibitors, St. John’s wort, and others may change Phase I/II balance. Hormonal contraception and HRT alter overall estrogen production and metabolite patterns.
-
Methylation capacity (COMT) & Phase II pathways: Adequate folate, B12, B6, magnesium, and choline/betaine support methylation; fiber and hydration aid glucuronidation/excretion.
-
Cycle timing & collection: Aim for consistent timing (many labs prefer early follicular) and a first-morning urine sample for comparisons.
What to do next (actionable plan)
If your 2-OH-E1 % is low (relative shift to 16-/4-OH):
-
Recheck under optimal collection conditions; 2) Review medications and alcohol/smoking; 3) Discuss with your clinician adding/lifestyle sources of crucifers and overall plant diversity; 4) Ensure adequate fiber (25–35 g/day), sleep, and exercise, which support Phase II clearance; 5) Consider whether I3C/DIM is appropriate (clinician-guided), especially if 16-OH is relatively high.
If your 2-OH-E1 % is high:
-
Confirm that 2-methoxy metabolites are also sufficient—good methylation helps neutralize catechols; 2) If methoxy is low, prioritize methylation nutrients (food-first; supplements only with guidance), manage alcohol, and consider stress/sleep optimization; 3) Keep perspective—a high percentage alone isn’t harmful, but balance across pathways matters.
If any result is far outside range or symptoms are significant (cycle irregularity, heavy bleeding, hot flashes/night sweats out of the expected life stage, new breast symptoms): follow up with your clinician for targeted serum testing (estradiol, estrone, SHBG), pelvic evaluation when appropriate, and a review of thyroid, iron, and metabolic markers.
FAQs
Does a higher 2-OH-E1 % mean lower breast-cancer risk?
Not necessarily. Research on ratios/percentages and risk is mixed. Use this marker to understand metabolism, not to predict risk or guide treatment by itself.
Can I fix a “low” 2-OH-E1 % with supplements?
Sometimes dietary changes (crucifers, fiber, whole-foods pattern) help. Supplements like DIM/I3C can alter metabolism but aren’t for everyone—work with your clinician and re-test rather than self-treating.
Is more 2-OH always better?
No. The key is balance and downstream methylation (adequate 2-methoxy). An extreme shift without good Phase II support isn’t the goal.
Key takeaways
-
2-OH-E1 % shows the share of estrone routed to 2-hydroxylation; it’s a distribution metric, not a disease diagnosis.
-
Low %: relative shift toward 16-/4-OH; consider diet, lifestyle, and medication factors.
-
High %: more 2-OH routing—fine if 2-methoxy is adequate; if not, consider methylation support.
-
Aim for balanced pathways within your lab’s ranges, guided by your symptoms and clinician input.
All Your Lab Results.
One Simple Dashboard.
Import, Track, and Share Your Lab Results Easily
Import, Track, and Share Your Lab Results
Import lab results from multiple providers, track changes over time, customize your reference ranges, and get clear explanations for each result. Everything is stored securely, exportable in one organized file, and shareable with your doctor—or anyone you choose.
Cancel or upgrade anytime
What does it mean if your 2-OH-E1 % (Pre-menopausal) result is too low?
A decreased 2-OH-E1 % means a smaller share of your estrone is being metabolized through the 2-hydroxylation route and more is being shunted toward 4-OH and/or 16-OH pathways. It does not mean your overall estrogen is low—it reflects how your body is processing estrogen, not how much you make.
Why it can be low
-
Enzyme balance: Relatively lower activity of Phase I enzymes that favor 2-hydroxylation (e.g., CYP1A family), or relatively higher activity of pathways that form 16-OH or 4-OH metabolites.
-
Lifestyle and diet: Low intake of cruciferous vegetables (broccoli, kale, cabbage), low overall plant diversity/fiber, high alcohol intake, or high exposure to environmental stressors can shift pathway percentages.
-
Medications/supplements: Enzyme inducers/inhibitors (various prescription meds and botanicals) may alter Phase I balance; hormonal contraception/HRT changes the whole estrogen milieu and its metabolites.
-
Collection/timing: Non–first-morning samples, very dilute urine, or different cycle days can nudge borderline percentages. Always compare to your lab’s reference range.
How to read your result
-
Mildly low: Common and often transient. Re-check with an optimized collection to confirm.
-
Persistently low: Look at the pattern with partner markers—16-OH-E1 %, 4-OH-E1 %, and 2-methoxy metabolites. A low 2-OH-E1 % with high 16-OH suggests a different plan than a low 2-OH with high 4-OH.
-
Remember: This marker does not diagnose disease or predict cancer risk on its own. It’s a metabolism snapshot to guide sensible, food-first adjustments and, when appropriate, targeted clinical follow-up.
Practical next steps
-
Confirm correctly: Repeat using a first-morning urine sample, keep collection consistent (many labs prefer early follicular phase), and limit alcohol for 24–48 hours beforehand.
-
Review the pattern: Check 16-OH-E1 %, 4-OH-E1 %, and 2-methoxy metabolites to see where estrogen is being routed and whether methylation (COMT) looks supported.
-
Food-first support for balance:
-
Emphasize cruciferous vegetables and overall plant diversity.
-
Aim for 25–35 g/day of fiber, adequate protein, and hydration to support Phase II clearance.
-
Moderate alcohol; prioritize sleep and regular activity.
-
-
Consider supplements only with your clinician: Compounds like I3C/DIM can tilt metabolism toward 2-hydroxylation but aren’t for everyone; re-test rather than self-treat.
-
Medication and exposure check: Discuss prescription meds/botanicals that influence liver enzymes; address tobacco smoke and other exposures that skew Phase I/II balance.
Key takeaways
-
Decreased 2-OH-E1 % reflects a relative shift away from the 2-hydroxylation route; it does not equal “low estrogen.”
-
Interpret in context with 16-OH, 4-OH, and 2-methoxy partners, your symptoms, and cycle timing.
-
Focus on balanced pathways via food-first strategies and clinician-guided changes; confirm improvements with a repeat test.
Laboratories
Bring All Your Lab Results Together — In One Place
We accept reports from any lab, so you can easily collect and organize all your health information in one secure spot.
Pricing Table
Gather Your Lab History — and Finally Make Sense of It
Finally, Your Lab Results Organized and Clear
Personal plans
$79/ year
Advanced Plan
Access your lab reports, explanations, and tracking tools.
- Import lab results from any provider
- Track all results with visual tools
- Customize your reference ranges
- Export your full lab history anytime
- Share results securely with anyone
- Receive 5 reports entered for you
- Cancel or upgrade anytime
$250/ once
Unlimited Account
Pay once, access everything—no monthly fees, no limits.
- Import lab results from any provider
- Track all results with visual tools
- Customize your reference ranges
- Export your full lab history anytime
- Share results securely with anyone
- Receive 10 reports entered for you
- No subscriptions. No extra fees.
$45/ month
Pro Monthly
Designed for professionals managing their clients' lab reports
- Import lab results from any provider
- Track lab results for multiple clients
- Customize reference ranges per client
- Export lab histories and reports
- Begin with first report entered by us
- Cancel or upgrade anytime
About membership
What's included in a Healthmatters membership
Import Lab Results from Any Source
See Your Health Timeline
Understand What Your Results Mean
Visualize Your Results
Data Entry Service for Your Reports
Securely Share With Anyone You Trust
Let Your Lab Results Tell the Full Story
Once your results are in one place, see the bigger picture — track trends over time, compare data side by side, export your full history, and share securely with anyone you trust.
Bring all your results together to compare, track progress, export your history, and share securely.
What Healthmatters Members Are Saying
Frequently asked questions
Healthmatters is a personal health dashboard that helps you organize and understand your lab results. It collects and displays your medical test data from any lab in one secure, easy-to-use platform.
- Individuals who want to track and understand their health over time.
- Health professionals, such as doctors, nutritionists, and wellness coaches, need to manage and interpret lab data for their clients.
With a Healthmatters account, you can:
- Upload lab reports from any lab
- View your data in interactive graphs, tables, and timelines
- Track trends and monitor changes over time
- Customize your reference ranges
- Export and share your full lab history
- Access your results anytime, from any device
Professionals can also analyze client data more efficiently and save time managing lab reports.
Healthmatters.io personal account provides in-depth research on 10000+ biomarkers, including information and suggestions for test panels such as, but not limited to:
- The GI Effects® Comprehensive Stool Profile,
- GI-MAP,
- The NutrEval FMV®,
- The ION Profile,
- Amino Acids Profile,
- Dried Urine Test for Comprehensive Hormones (DUTCH),
- Organic Acids Test,
- Organix Comprehensive Profile,
- Toxic Metals,
- Complete Blood Count (CBC),
- Metabolic panel,
- Thyroid panel,
- Lipid Panel,
- Urinalysis,
- And many, many more.
You can combine all test reports inside your Healthmatters account and keep them in one place. It gives you an excellent overview of all your health data. Once you retest, you can add new results and compare them.
If you are still determining whether Healthmatters support your lab results, the rule is that if you can test it, you can upload it to Healthmatters.
We implement proven measures to keep your data safe.
At HealthMatters, we're committed to maintaining the security and confidentiality of your personal information. We've put industry-leading security standards in place to help protect against the loss, misuse, or alteration of the information under our control. We use procedural, physical, and electronic security methods designed to prevent unauthorized people from getting access to this information. Our internal code of conduct adds additional privacy protection. All data is backed up multiple times a day and encrypted using SSL certificates. See our Privacy Policy for more details.